Sunday, September 20, 2009

controversial chemical.

Baby boys are more likely to have changes in their genitals — such as undescended testicles and smaller penises — if their mothers were exposed to high levels of a controversial chemical during pregnancy, a new study shows. Virtually everyone has been exposed to the chemicals, called phthalates, which are used in countless plastic products and are found in everything from drinking water to breast milk to household dust, according to the study, published in the current issue of Environmental Research.

Until recently, most studies have been conducted in animals. Those tests suggest that phthalates interfere with the male sex hormone testosterone, causing a "phthalate syndrome" in male fetuses that changes the way their genitals develop, says study author Shanna Swan, a professor at the University of Rochester School of Medicine and Dentistry.

Swan says her study of 106 mothers and sons suggests this syndrome may be occurring in humans, too. In her study, doctors measured phthalate levels in the mothers' urine during pregnancy, then examined the babies at 12 months.

Boys whose mothers had the highest phthalate levels were more likely than others to show three anatomic differences: smaller penises, a shorter distance between the anus and base of the penis, and undescended or incompletely descended testicles, Swan says. Swan also notes that most boys had normal sex organs. Twelve had incompletely descended testicles, while 29 babies fell into a category with "shorter" anogenital distances.

In most cases, these aren't serious problems, Swan says. Babies with undescended testicles often need no treatment, because the organs descend on their own by age 1. Others can be helped with hormone treatments or surgery. And even the smaller penises appeared to be within the normal range.

But Swan says she's concerned that these changes indicate a deeper problem — that phthalates may have made the boys "less masculine" in key ways. In animals, males with these genital changes also had lower sperm counts, she says.

Swan says she is also concerned about girls. It's possible that any effects from pre-birth phthalate exposure may not surface until the girls hit puberty or try to have children, she says.

In her paper, she notes that other researchers have linked phthalates to reduced sperm quality and DNA damage, as well as hormone changes, reduced lung function and premature puberty.

continue reading »»

Chemical Biology 2009.

Conferences; HIV / AIDS; Biology / Biochemistry

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

In the field of chemical biology, chemists and biologists cooperate to investigate, and eventually control, the behavior of cells. The scientists use small molecules that activate certain proteins to study how cells communicate, and ultimately they want to be able to prevent disease-causing interactions and understand how medicines and environmental toxins work on a cellular level.

The potential applications of research in chemical biology are unlimited. A number of serious diseases that lack effective treatments are currently being studied. Many of them will be discussed on 24-25 August when the University of Gothenburg and Chalmers University of Technology host the Functional Genomics/Chemical Biology conference in Gothenburg, Sweden: Professor Carsten Schultz from the European Molecular Biology Laboratory (EMBL) in Heidelberg is developing new tools that will help us better understand cystic fibrosis. By visualising how cell signaling goes awry, Schultz hopes to come closer to finding a treatment for the incurable disease.

Ronald Raines from the University of Wisconsin has designed a 'Trojan horse' - an enzyme that infiltrates and then attacks the viruses that cause HIV and the lung disease SARS.

Guri Giaever from the University of Toronto uses yeast to investigate the action mechanism of medicines. Giaver is working together with pharmaceutical companies to explore and eliminate side effects of medicines.

Henrik Pavia is a University of Gothenburg marine ecologist and an expert in how marine organisms produce and utilise chemical substances. At the conference, Pavia will share the latest knowledge on how these marine bioactive substances can be used to create medicines for humans.
The conference, held at the Chalmers Conference Centre, will also present new findings about environmental toxins and the research currently carried out to identify how molecules in the cell are affected by the toxins.

continue reading »»
Share |
Blog Advertising
Get paid To Promote at any Location